Cyclosporin improves Graves' ophthalmopathy

Area of Science:

• Endocrinology
• Immunology
• Ophthalmology

Background:

• Graves' ophthalmopathy is an autoimmune condition affecting the eyes.
• Current treatments for Graves' ophthalmopathy have limitations.

Observation:

• Two patients with active Graves' ophthalmopathy received cyclosporin treatment.
• Objective clinical assessments and laboratory markers were monitored.

Findings:

• Cyclosporin led to rapid, objective improvements in ocular muscle function, visual acuity, and exophthalmos.
• Orbital muscle swelling decreased, as confirmed by CT scans.
• Treatment reduced thyroid autoantibody levels and normalized T-cell subset abnormalities.
• One patient showed a normalized thyrotropin response to thyrotropin-releasing hormone.

Implications:

• Cyclosporin shows promise as a treatment for the congestive ophthalmopathy of Graves' disease.
• Further investigation into cyclosporin's efficacy and safety in Graves' ophthalmopathy is warranted.